	Engineering human brain microphysiological systems for alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions. Adv Drug Deliv Rev Yun Y, Jena S, Egido-Betancourt H, Uzoechi S, Kim DY, Lee JM, Nguyen J. PMID: 42950990 [PubMed - as supplied by publisher]
	The orexinergic-endocannabinoid interface: mechanistic and therapeutic perspectives in Alzheimer's disease, anxiety, and visceral pain. Neuropeptides Bodke S, Shelke P, Bhatt LK. PMID: 42950713 [PubMed - as supplied by publisher]
	Neuropathological Correlates of Apathy Progression in Alzheimer Disease and Related Dementias: A Longitudinal NACC Cohort Study. Alzheimer Dis Assoc Disord Qi YA, Goldberg TE, Kim H, Devanand DP, Lee S. PMID: 42949266 [PubMed - as supplied by publisher]
	The Target48 Neurodegeneration panel: A novel tool for profiling protein signatures in neurodegenerative disorders. Alzheimers Dement Hok-A-Hin YS, Vermunt L, de Jong N, Del Campo Milan M, Vijverberg E, Lemstra AW, Pijnenburg Y, van Harten AC, Teunissen CE. PMID: 42949229 [PubMed - indexed for MEDLINE]
	Using the 4Cs of Primary Care to Ensure Timely Diagnosis of Alzheimer Disease. Alzheimer Dis Assoc Disord Shah RC, Borson S, Luchsinger JA. PMID: 42949022 [PubMed - as supplied by publisher]
	Blood-Based Biomarkers in Alzheimer's Disease: Advances in Detection Technologies and Clinical Applications. Aging Med (Milton) Li S, Huang L, Guo Q. PMID: 42948835 [PubMed - as supplied by publisher]
	Application of computational methods in the drug discovery and development of Alzheimer's disease. Acta Pharm Sin B Zhang Q, Gong X, Liu H, Yao X. PMID: 42948713 [PubMed]
	Digital completion time relates more strongly to Alzheimer's disease-type atrophy than to vascular burden in a community cohort. Alzheimers Dement (Amst) Iwasa K, Omori N, Ishida M, Tanaka T, Nagai A. PMID: 42948203 [PubMed]
	Perspectives on plasma biomarkers for point-of-care diagnostics in Alzheimer's disease: Insights into 2D-BioPAD. J Alzheimers Dis Rep Koukoura A, Antonopoulou K, Tsolakis AC, Solomon A, Tsolaki M, Froelich L, Tsolaki A, Papadaki E, Vassiliadis E, Holst GJ. PMID: 42948155 [PubMed]
	ConvNeXt-KAN: a Kolmogorov-Arnold Network head for robust multi-class staging of Alzheimer's disease from brain MRI. Front Artif Intell Islam K, Hossen B, Manjar MTA, Sultana S. PMID: 42947994 [PubMed]
	Dynamic remodeling of microglial responses in Alzheimer's disease: heterogeneous states, spatiotemporal progression, and immunometabolic dysregulation. Front Cell Dev Biol Han S, Wang S, Liu J, Liu X, Wang Q, Meng C. PMID: 42947965 [PubMed]
	Deep brain stimulation in Alzheimer's disease. J Alzheimers Dis Rep Majeed Z, Majeed J, Ponce FA, Mahanti H, Decourt B, Burke AD, Sabbagh MN. PMID: 42947905 [PubMed]
	Caregiver positivity as a psychosocial modifier of lecanemab-related outcomes in Alzheimer's disease: A multicenter longitudinal study in China. Alzheimers Dement Wu W, Liu H, Liang Y, Li H, Zhang J, Sun Z, Song Y, Fei M, Wu H, Jiang M, Fan S, Zhou C, Cao Y, Chen H, Liu S. PMID: 42947278 [PubMed - indexed for MEDLINE]
	Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort. Alzheimers Res Ther Beament M, Wiltshire K, Belder CRS, Abel E, Hart M, Heslegrave AJ, Lunn MP, Rosa-Grilo M, Swann O, Schott JM, Zetterberg H, Fox NC, Keshavan A. PMID: 42947225 [PubMed - indexed for MEDLINE]
	Menopause and Alzheimer's disease: can hormone replacement therapy modify the risk? A narrative review. BMC Womens Health Wang JY, Ansorge O. PMID: 42947097 [PubMed - indexed for MEDLINE]
	Simpson's Paradox, Amyloid Paradox, and Racial Differences. JAMA Netw Open Xiong C, Luo J, Lu R, Hartz S, Kukull W, Schindler SE, Balls-Berry JE, Hassenstab J, Wolk DA, Gleason CE, Johnson SC, Sperling R, Johnson K, Roberson ED, Moulder KL, Gremminger E, Agboola F, Grant EA, Hornbeck R, Massoumzadeh P, Keefe S, Dierker D, Flores S, Holtzman DM, Benzinger T, Morris JC. PMID: 42944683 [PubMed - indexed for MEDLINE]
	Natural Compounds and Their Microbiota-Derived Metabolites as Modulators of the Microbiota-Gut-Brain Axis in Alzheimer Disease: Biochemical Mechanisms and Drug Discovery Insights-A Narrative Review. Molecules Cavalluzzi MM, Terlizzi F, Catalano A, Pannunzio A, Rotondo NP, Habtemariam S, Lentini G. PMID: 42943797 [PubMed - indexed for MEDLINE]
	Alpiniae oxyphyllae Fructus in Alzheimer's Disease: Multi-Target Mechanisms, Current Evidence, and Future AI-Driven Perspectives. Molecules Qin Q, Yan Q, Zhu K, Miao J, Yang M, Wu Z, Fan C, Jiang P, Wu G, Wang Q. PMID: 42943751 [PubMed - indexed for MEDLINE]
	Flocculent Ti(3)AlC(2)-Based Two-Dimensional Material Flexible Microneedle Patch for Screening Alzheimer's Disease Animal Biomarkers and In Situ Revealing Spatial Aggregation of Arachidonic Acid. Molecules Chen S, Li B, Zhao T, Huang Q, Li C, Ainiwan Y, Qi S, Pan J. PMID: 42943736 [PubMed - indexed for MEDLINE]
	Integrated Genetic and Multi-Omic Analyses Reveal Oral Microbial Associations with Brain Structure and Alzheimer's Disease. Microorganisms Liu Y, Feng X, Dong H, Lan T, Wu J, Wang C, Zhang X. PMID: 42943397 [PubMed]

Articles 1 - 20 / 72936

Page 1 of 3647



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy